Cargando…

Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study

BACKGROUND: This study aimed to evaluate the association between adherence to maintenance medication (ie, inhaled bronchodilators, inhaled corticosteroid/long-acting beta-2 agonist [ICS/LABA] combinations, and oral therapy) and acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Rongchang, Gao, Yue, Wang, He, Shang, Hongyan, Xuan, Jianwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210029/ https://www.ncbi.nlm.nih.gov/pubmed/32440108 http://dx.doi.org/10.2147/COPD.S234349

Ejemplares similares

Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD
por: Dalal, Anand A, et al.
Publicado: (2012)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jardim, Jose R., et al.
Publicado: (2019)

Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data
por: Li, Meng, et al.
Publicado: (2018)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Effectiveness of Telemonitoring for Reducing Exacerbation Occurrence in COPD Patients With Past Exacerbation History: A Systematic Review and Meta-Analysis
por: Lu, Jing-wen, et al.
Publicado: (2021)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2018)

Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
por: Salem, Ahmed, et al.
Publicado: (2021)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
por: Price, David, et al.
Publicado: (2016)

Effects of Adherence to an mHealth Tool for Self-Management of COPD Exacerbations
por: Bischoff, Erik W M A, et al.
Publicado: (2023)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy
por: Moretz, Chad, et al.
Publicado: (2020)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Utility of the CAT in the therapy assessment of COPD exacerbations in China
por: Tu, You-Hui, et al.
Publicado: (2014)

The use of antibiotics in treatment of acute COPD exacerbations does not adhere to national guidelines
por: Nielsen, Hanne, et al.
Publicado: (2010)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

Switching treatments in COPD: implications for costs and treatment adherence
por: Braido, Fulvio, et al.
Publicado: (2015)

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study
por: Slade, David, et al.
Publicado: (2021)

Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil?
por: Morakami, Fernanda Kazmierski, et al.
Publicado: (2017)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
por: Gong, Yaya, et al.
Publicado: (2022)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Comparison of the accuracy of classification models to estimate healthcare use and costs associated with COPD exacerbations in Saskatchewan, Canada: A retrospective cohort study
por: Kuwornu, John Paul, et al.
Publicado: (2017)

Low human beta-defensin-2 levels in the sputum of COPD patients are associated with the risk of exacerbations
por: Feng, Shengchuan, et al.
Publicado: (2023)

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study
por: Margüello, Miguel Santibañez, et al.
Publicado: (2016)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

COPD exacerbation frequency and its association with health care resource utilization and costs
por: Dhamane, Amol D, et al.
Publicado: (2015)

Rising total costs and mortality rates associated with admissions due to COPD exacerbations
por: Molinari, Nicolas, et al.
Publicado: (2016)

The frequent and underrecognised co-occurrence of acute exacerbated COPD and depression warrants screening: a systematic review
por: Lecheler, Leopold, et al.
Publicado: (2017)

Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population
por: Coutinho, Anna D, et al.
Publicado: (2016)

Glycemic Control & Morbidity in Diabetics With COPD Exacerbation. A Retrospective Study
por: Naoum, Ibrahim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k72ds6lpbrc6sr5b38nh2dhtpr